Related Experiment Video
Updated: Sep 28, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk
Jianfeng Xu1, S Lilly Zheng, Akira Komiya
1Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. jxu@wfubmc.edu
Abstract:
Rare germline mutations of macrophage scavenger receptor 1 (MSR1) gene were reported to be associated with prostate cancer risk in families with hereditary prostate cancer (HPC) and in patients with non-HPC (Xu et al. 2002). To further evaluate the role of MSR1 in prostate cancer susceptibility, at Johns Hopkins Hospital, we studied five common variants of MSR1 in 301 patients with non-HPC who underwent prostate cancer treatment and in 250 control subjects who participated in prostate cancer-screening programs and had normal digital rectal examination and PSA levels (<4 ng/ml). Significantly different allele frequencies between case subjects and control subjects were observed for each of the five variants (P value range.01-.04). Haplotype analyses provided consistent findings, with a significant difference in the haplotype frequencies from a global score test (P=.01). Because the haplotype that is associated with the increased risk for prostate cancer did not harbor any of the known rare mutations, it appears that the observed association of common variants and prostate cancer risk are independent of the effect of the known rare mutations. These results consistently suggest that MSR1 may play an important role in prostate carcinogenesis.
Insights
Common variants in the macrophage scavenger receptor 1 (MSR1) gene are linked to increased prostate cancer risk. These findings suggest MSR1 plays a significant role in prostate carcinogenesis, independent of rare mutations.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Germline mutations in the macrophage scavenger receptor 1 (MSR1) gene have been previously associated with prostate cancer risk.
- Hereditary prostate cancer (HPC) and non-HPC patient cohorts have shown links to MSR1 gene mutations.
Purpose of the Study:
- To investigate the association between common variants of the MSR1 gene and prostate cancer susceptibility.
- To evaluate the role of MSR1 in the development of non-hereditary prostate cancer.
Main Methods:
- A case-control study involving 301 patients with non-HPC and 250 healthy controls.
- Analysis of five common MSR1 gene variants and haplotype analysis.
Main Results:
- Significantly different allele frequencies for all five studied MSR1 variants were observed between prostate cancer cases and controls (P values ranging from .01 to .04).
- Haplotype analyses revealed significant differences in frequencies (global score test, P=.01).
- The MSR1 haplotype associated with increased prostate cancer risk did not contain known rare mutations, indicating an independent effect.
Conclusions:
- Common variants of the MSR1 gene are associated with prostate cancer susceptibility.
- MSR1 may play a significant role in prostate carcinogenesis, independent of previously identified rare mutations.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Single Nucleotide Polymorphisms-SNPs
Cancer Prevention
Some...

